Stay updated with breaking news from Askgene Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative...
AffaMed Therapeutics has announced dosing of the first subject in the Phase I clinical trial of AM712 to treat retinal diseases in the US.
FinancialContent fully hosted finance channel
/PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biotechnology company dedicated to developing and commercializing transformative...
/PRNewswire/ -- The "Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An...